Chengkai Dai was appointed as senior investigator for the NCI Mouse Cancer Genetics Program – NCI Center for Cancer Research
NCI Center for Cancer Research shared a post on LinkedIn:
“FACULTY NEWS: Congratulations to Chengkai Dai, for receiving tenure and being appointed as a Senior Investigator in the National Cancer Institute (NCI) Mouse Cancer Genetics Program.
Dr. Dai is a pioneer in the field of proteomic instability of cancer.
The recent findings from his laboratory have revealed the intimate interactions between the proteotoxic stress response and RAS/MAPK-MEK signaling, cell cycle regulation, protein translation, as well as tumor-suppressive amyloidogenesis.
His ongoing research focuses on the molecular mechanisms through which proteomic instability may affect genomic stability, cell invasion, and autophagy, areas that hold promise to unveil new molecular pathways that could be targeted in cancer therapy.”
